Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
246.20B | 226.71B | 228.06B | 207.97B | 209.12B | 206.84B | Gross Profit |
114.46B | 104.78B | 106.80B | 101.09B | 87.75B | 84.46B | EBIT |
55.85B | 48.20B | 52.28B | 50.96B | 42.53B | 38.65B | EBITDA |
70.26B | 62.00B | 63.26B | 61.18B | 52.95B | 49.19B | Net Income Common Stockholders |
43.77B | 38.03B | 41.09B | 38.78B | 33.47B | 30.78B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
29.20B | 22.74B | 29.65B | 34.66B | 32.38B | 30.64B | Total Assets |
329.76B | 323.46B | 298.71B | 279.69B | 265.51B | 249.52B | Total Debt |
47.65B | 40.98B | 27.29B | 22.71B | 22.67B | 24.61B | Net Debt |
18.45B | 18.24B | -2.36B | -11.94B | -9.71B | -6.03B | Total Liabilities |
100.95B | 92.56B | 77.19B | 71.68B | 64.95B | 64.00B | Stockholders Equity |
225.63B | 227.47B | 218.42B | 205.91B | 198.83B | 183.92B |
Cash Flow | Free Cash Flow | ||||
30.07B | 12.70B | 15.05B | 29.10B | 30.40B | 25.97B | Operating Cash Flow |
47.36B | 33.70B | 35.23B | 41.95B | 39.94B | 35.55B | Investing Cash Flow |
-20.17B | -18.74B | -19.64B | -12.39B | -12.85B | -15.62B | Financing Cash Flow |
-23.55B | -22.10B | -25.03B | -27.87B | -25.63B | -25.19B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | ¥203.41B | 8.70 | 9.01% | 3.42% | 0.32% | 31.76% | |
71 Outperform | €585.06B | 13.55 | 19.18% | 3.87% | 9.83% | 22.31% | |
67 Neutral | $1.04T | 13.83 | 4.16% | 4.27% | <0.01% | -58.95% | |
64 Neutral | $625.16B | 12.37 | 5.83% | 4.49% | 5.15% | -8.48% | |
59 Neutral | €165.87B | 15.15 | 3.51% | 5.41% | 1.62% | 45.83% | |
51 Neutral | $585.47B | ― | -16.55% | 2.16% | 4.08% | -6.32% | |
49 Neutral | $1.97B | -1.18 | -21.24% | 3.71% | 1.29% | -31.16% |
Nissan Chemical Corporation has completed the repurchase of its own shares, acquiring a total of 695,400 shares for nearly 3 billion yen. This strategic move, executed on the Tokyo Stock Exchange, is part of a broader plan approved by the Board of Directors to enhance shareholder value and optimize capital structure.
Nissan Chemical Corporation has repurchased 330,000 of its own common shares from the market, amounting to a total purchase cost of 1,500,769,800 yen. This move is part of a broader strategy authorized by the Board of Directors to repurchase up to 750,000 shares, with a total budget of 3,000,000,000 yen, aimed at enhancing shareholder value and optimizing capital structure.
Nissan Chemical Corporation announced a decision to repurchase up to 750,000 of its own shares, representing 0.55% of the total shares outstanding, for up to 3 billion yen. This move is aimed at facilitating a flexible capital policy in response to changes in the business environment, potentially impacting the company’s financial strategy and market positioning.
Nissan Chemical Corporation announced the cancellation of 1,000,000 of its common shares, representing 0.73% of its issued shares, as part of a strategic move approved by its Board of Directors. This decision, scheduled to take effect on March 12, 2025, is expected to optimize the company’s capital structure and potentially enhance shareholder value.